Skip to content
10-Q

Quarterly Report

CELLULAR BIOMEDICINE GROUP, INC.

0001654954-20-012014

← back to feed
Filed
Nov 9, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 1, 2020 19.46M sh
Shares Diluted Q3 2020 · Sep 30, 2020 19.43M sh
Shares Diluted Q3 2020 · Sep 30, 2020 19.39M sh
Shares Diluted Q3 2020 · Sep 30, 2019 19.26M sh
Shares Diluted Q3 2020 · Sep 30, 2019 18.88M sh
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$33.17M
Operating Cash Flow restated Q3 2020 · Sep 30, 2019 −$28.36M
Short Term Debt Q3 2020 · Sep 30, 2020 $47.87M
Short Term Debt Q3 2020 · Dec 31, 2019 $14.33M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $26.03M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $0
Stockholders Equity Q3 2020 · Sep 30, 2020 $17.32M
Stockholders Equity Q3 2020 · Jun 30, 2020 $32.53M
Stockholders Equity Q3 2020 · Dec 31, 2019 $55.72M
Stockholders Equity Q3 2020 · Sep 30, 2019 $67.05M
Stockholders Equity Q3 2020 · Jun 30, 2019 $82.18M
Stockholders Equity Q3 2020 · Dec 31, 2018 $85.22M
Current Liabilities Q3 2020 · Sep 30, 2020 $59.3M
Current Liabilities Q3 2020 · Dec 31, 2019 $23.67M
Total Liabilities Q3 2020 · Sep 30, 2020 $75.76M
Total Liabilities Q3 2020 · Dec 31, 2019 $41.61M
Current Assets Q3 2020 · Sep 30, 2020 $27.87M
Current Assets Q3 2020 · Dec 31, 2019 $34.03M
Total Assets Q3 2020 · Sep 30, 2020 $93.09M
Total Assets Q3 2020 · Dec 31, 2019 $97.32M
Sga Expense Q3 2020 · Sep 30, 2020 $5.1M
Sga Expense Q3 2020 · Sep 30, 2020 $11.81M
Sga Expense Q3 2020 · Sep 30, 2019 $3.33M
Sga Expense Q3 2020 · Sep 30, 2019 $9.96M
Rd Expense Q3 2020 · Sep 30, 2020 $12.61M
Rd Expense Q3 2020 · Sep 30, 2020 $30.46M
Rd Expense Q3 2020 · Sep 30, 2019 $13.13M
Rd Expense Q3 2020 · Sep 30, 2019 $28.16M
Net Income Q3 2020 · Sep 30, 2020 −$17.04M
Net Income Q3 2020 · Sep 30, 2020 −$42.12M
Net Income Q3 2020 · Sep 30, 2019 −$15.86M
Net Income Q3 2020 · Sep 30, 2019 −$37.3M
Operating Income Q3 2020 · Sep 30, 2020 −$17.69M
Operating Income Q3 2020 · Sep 30, 2020 −$42.48M
Operating Income Q3 2020 · Sep 30, 2019 −$16.49M
Operating Income Q3 2020 · Sep 30, 2019 −$38.19M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $7.62K
Cost Of Revenue Q3 2020 · Sep 30, 2020 $7.62K
Cost Of Revenue Q3 2020 · Sep 30, 2019 $0
Cost Of Revenue Q3 2020 · Sep 30, 2019 $8.09K
Revenue Q3 2020 · Sep 30, 2020 $32.3K
Revenue Q3 2020 · Sep 30, 2020 $32.3K
Revenue Q3 2020 · Sep 30, 2019 $0
Revenue Q3 2020 · Sep 30, 2019 $49.27K